Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Committee hears experts on 340B program growth and transparency as lawmakers consider oversight bill
Summary
Witnesses told the committee that the 340B drug-pricing program has grown dramatically, with hospitals and contract pharmacies increasingly positioned to benefit; committee members signaled interest in transparency measures and further technical work.
Late in the Feb. 16 session the committee heard expert testimony on 340B, a federal drug-pricing program that gives covered hospitals and clinics access to discounted drug prices. William Smith, a researcher who studies 340B, summarized program changes: participation has grown from under 3,000 covered entities in earlier years to more than 14,000 hospitals and clinics and tens of thousands of…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
